Covance

Covance launches external laboratory management services

Wednesday, September 25, 2013 12:36 PM

CRO Covance has launched external laboratory management services, a new offering that provides biopharmaceutical companies with a management solution for external laboratory testing associated with clinical trials.

More... »

Covance, Indiana CTSI collaborate

Wednesday, September 4, 2013 12:28 PM

CRO Covance and the Indiana Clinical and Translational Sciences Institute (CTSI), part of the Indiana University (IU) School of Medicine, will collaborate to conduct early clinical trials for new medicines. 

More... »

Covance launches managed markets services

Friday, August 9, 2013 01:04 PM

Princeton, N.J.-based CRO Covance has created a new service offering focused on providing its biopharmaceutical and medical device clients support to effectively manage contracts in managed markets.

More... »

The CenterWatch Monthly, August 2013

Friday, August 2, 2013 10:36 AM

Will end-to-end outsourcing take hold?

More... »

Covance: Survey of investigators rates it first in central lab services

Tuesday, July 30, 2013 01:44 PM

CRO Covance said its central laboratory services once again ranked first in an independent global survey of physician investigators in clinical trials. Of the study participants, 47% named Covance’s central lab services as their "most preferred" central lab, with investigators citing Covance more than twice as often as the nearest competitor.  Investigators also reported having the "best overall relationship" with Covance, rating it 8.4 on a scale of 1 to 10.

More... »

Covance, NAFC provide 800 New Orleans patients free medical care

Wednesday, July 10, 2013 12:06 PM

CRO Covance has reached more than 800 uninsured and underinsured patients in the New Orleans area through a free health clinic held July 3 in partnership with the National Association of Free and Charitable Clinics (NAFC). More than 800 volunteers—including 35 Covance employees—participated in the NAFC’s Communities Are Responding Everyday Clinic (C.A.R.E.), sponsored by the Covance Charitable Foundation.

More... »

Covance expands Singapore central lab by 50%

Monday, April 22, 2013 12:44 PM

Covance, a provider of drug development services, has completed the expansion of its central laboratory facility in Singapore to enhance the company’s current service offerings and position it to meet current and future growth of drug development in the Asia Pacific region. The expansion is the latest in Covance’s continued investment in Singapore, and an important element of the strategic investment plans for the Asia Pacific region that also includes recent growth in operations in China and Japan.

More... »

Covance, M2Gen to promote faster patient recruitment in biomarker-driven oncology trials

Tuesday, February 26, 2013 09:35 AM

Covance, a Princeton, N.J.-based provider of drug development services, has entered into an exclusive alliance and services agreement with M2Gen, a subsidiary of the Moffitt Cancer Center and developer of personalized cancer treatments.

More... »

Synteract appoints Kelson as CFO, Doren as vice president of biometrics

Wednesday, January 30, 2013 03:18 PM

Synteract, a full service CRO based in Carlsbad, Calif., has hired new executives to support customers on a global scale. Keith Kelson will serve as chief financial officer and member of its executive council, and Phil Doren has been appointed vice president of biometrics.

More... »

Covance launches five-year collaboration on early clinical research

Friday, January 18, 2013 01:23 PM

Global CRO Covance and the Royal Liverpool and Broadgreen University Hospitals NHS Trust have entered into a five-year exclusive agreement to work together in conducting early clinical trials at the Royal Liverpool University Hospital on behalf of biotechnology and pharmaceutical companies.

More... »